EIM
RCEL icon

Essex Investment Management’s Avita Medical RCEL Stock Holding History

Essex Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-261,171
Closed -$3.34M – 321
2024
Q4 		$3.34M Buy
261,171
+30,077
+13% +$355K 0.6% 63
2024
Q3 		$2.48M Buy
+231,094
New +$2.17M 0.43% 103

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Essex Investment Management's RCEL Position: Q1 2025 in Review

Essex Investment Management sold out of Avita Medical (RCEL) in Q1 2025, closing a stake of 261,171 shares — an estimated $3.34M sold.

Essex Investment Management first reported a position in RCEL in Q3 2024 and held it in 2 quarters. The position peaked at $3.34M in Q4 2024. 74 funds tracked by Wall St. Rank hold RCEL as of Q1 2025.

  • Essex Investment Management reported no remaining Avita Medical position as of Q1 2025 after selling out during the quarter.
  • Essex Investment Management sold 261,171 Avita Medical shares in Q1 2025, an estimated $3.34M.
  • Essex Investment Management first reported a position in Avita Medical in Q3 2024 and held it in 2 quarters.
  • Essex Investment Management's Avita Medical position peaked at $3.34M in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q1 2025.

Based on Essex Investment Management's 13F filing for Q1 2025, filed 7 May 2025.